BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND BAP1, DKFZp686N04275, 8314, ENSG00000163930, Q92560, KIAA0272, hucep-6, HUCEP-13, FLJ37180, FLJ35406 AND Staging
6 results:

  • 1. Mesotheliomas and Benign Mesothelial Tumors: Update on Pathologic and Imaging Findings.
    Bonde A; Singh R; Prasad SR; Kamireddy D; Aggarwal A; Ramani N; Saboo S; Shanbhogue K; Dasyam AK; Katabathina VS
    Radiographics; 2023 Mar; 43(3):e220128. PubMed ID: 36757881
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The highlights of the 15th international conference of the international mesothelioma interest group - Do molecular concepts challenge the traditional approach to pathological mesothelioma diagnosis?
    Klebe S; Galateau Salle F; Bruno R; Brcic L; I Chen-Yost H; Jaurand MC
    Lung Cancer; 2022 Jan; 163():1-6. PubMed ID: 34864334
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma.
    Scherpereel A; Opitz I; Berghmans T; Psallidas I; Glatzer M; Rigau D; Astoul P; Bölükbas S; Boyd J; Coolen J; De Bondt C; De Ruysscher D; Durieux V; Faivre-Finn C; Fennell D; Galateau-Salle F; Greillier L; Hoda MA; Klepetko W; Lacourt A; McElnay P; Maskell NA; Mutti L; Pairon JC; Van Schil P; van Meerbeeck JP; Waller D; Weder W; Cardillo G; Putora PM
    Eur Respir J; 2020 Jun; 55(6):. PubMed ID: 32451346
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma.
    Opitz I; Scherpereel A; Berghmans T; Psallidas I; Glatzer M; Rigau D; Astoul P; Bölükbas S; Boyd J; Coolen J; De Bondt C; De Ruysscher D; Durieux V; Faivre-Finn C; Fennell DA; Galateau-Salle F; Greillier L; Hoda MA; Klepetko W; Lacourt A; McElnay P; Maskell NA; Mutti L; Pairon JC; Van Schil P; van Meerbeeck JP; Waller D; Weder W; Putora PM; Cardillo G
    Eur J Cardiothorac Surg; 2020 Jul; 58(1):1-24. PubMed ID: 32448904
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. EURACAN/IASLC Proposals for Updating the Histologic Classification of Pleural Mesothelioma: Towards a More Multidisciplinary Approach.
    Nicholson AG; Sauter JL; Nowak AK; Kindler HL; Gill RR; Remy-Jardin M; Armato SG; Fernandez-Cuesta L; Bueno R; Alcala N; Foll M; Pass H; Attanoos R; Baas P; Beasley MB; Brcic L; Butnor KJ; Chirieac LR; Churg A; Courtiol P; Dacic S; De Perrot M; Frauenfelder T; Gibbs A; Hirsch FR; Hiroshima K; Husain A; Klebe S; Lantuejoul S; Moreira A; Opitz I; Perol M; Roden A; Roggli V; Scherpereel A; Tirode F; Tazelaar H; Travis WD; Tsao MS; van Schil P; Vignaud JM; Weynand B; Lang-Lazdunski L; Cree I; Rusch VW; Girard N; Galateau-Salle F
    J Thorac Oncol; 2020 Jan; 15(1):29-49. PubMed ID: 31546041
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. PAX8 Expression in a Subset of Malignant Peritoneal Mesotheliomas and Benign Mesothelium has Diagnostic Implications in the Differential Diagnosis of Ovarian Serous Carcinoma.
    Chapel DB; Husain AN; Krausz T; McGregor SM
    Am J Surg Pathol; 2017 Dec; 41(12):1675-1682. PubMed ID: 28877056
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.